Drug · DIN 00499013
MANDELAMINE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 18, 2024; first marketed December 31, 1951.
- Drug Identification Number (DIN)
- 00499013
- Company (DIN owner)
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Methenamine J01XX05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHENAMINE MANDELATE | 500 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 26, 2022: NOC 29306New Drug Submission (NDS) · Administrative: Change in Product Ownership
- August 17, 2005: NOC 7292New Drug Submission (NDS) · Manufacturer name change
- January 23, 2001: NOC 2453New Drug Submission (NDS) · Manufacturer name change